<DOC>
	<DOCNO>NCT02692261</DOCNO>
	<brief_summary>Sinus augmentation predictable method alveolar bone height sufficient dental implant placement posterior maxillary alveolar region..The aim prospective , randomize , control clinical study comparison hyaluronic acid originate matrix equine derive xenograft xenograft use sinus augmentation micro compute tomography histomorphometry .</brief_summary>
	<brief_title>Hyaluronic Matrix Efficacy Maxillary Sinus Augmentation</brief_title>
	<detailed_description />
	<criteria>Systemically healthy patient Requiring bilateral maxillary sinus augmentation ( residual crest height â‰¤ 4 mm ) Advanced systemic disease Chronic medication use Maxillary sinus disease Current pregnancy Lactation Smoking habit</criteria>
	<gender>All</gender>
	<minimum_age>33 Years</minimum_age>
	<maximum_age>69 Years</maximum_age>
	<verification_date>February 2016</verification_date>
</DOC>